Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

1
Player Avatar NHWeston (< 20) Submitted: 11/30/2012 1:57:36 PM : Outperform Start Price: $1.70 LXRX Score: -56.12

A small company that gets very little attention, working in apparently random areas like bowel issues and rheumatiod arthritis. Diabetes, however, is a research zone where they've suddenly picked up and, with a current price slip, insiders and board members are accumulating shares hand over fist. Speculative, but promising.

Featured Broker Partners


Advertisement